Drug Shortage Report for DEFEROXAMINE MESYLATE FOR INJECTION

Last updated on 2025-03-12 History
Report ID 243092
Drug Identification Number 02247022
Brand name DEFEROXAMINE MESYLATE FOR INJECTION
Common or Proper name DEFEROXAMINE MESYLATE FOR INJECTION
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DEFEROXAMINE MESYLATE
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2g vial
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-01-31
Estimated end date
Actual end date 2025-03-11
Shortage status Resolved
Updated date 2025-03-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-03-12 English Compare
v10 2025-03-11 French Compare
v9 2025-03-11 English Compare
v8 2025-02-01 English Compare
v7 2025-01-31 French Compare
v6 2025-01-31 English Compare
v5 2025-01-21 English Compare
v4 2025-01-17 French Compare
v3 2025-01-17 English Compare
v2 2024-11-14 French Compare
v1 2024-11-14 English Compare

Showing 1 to 11 of 11